Lifevantage (NASDAQ:LFVN) Share Price Crosses Above 200-Day Moving Average – Here’s Why

Lifevantage Corporation (NASDAQ:LFVN)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $5.72 and traded as high as $6.59. Lifevantage shares last traded at $6.37, with a volume of 75,057 shares changing hands.

Wall Street Analyst Weigh In

LFVN has been the subject of several research analyst reports. Weiss Ratings upgraded Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, May 26th. Lake Street Capital downgraded Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target for the company. in a research note on Thursday, May 7th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $5.00.

Lifevantage Stock Performance

The company has a market capitalization of $80.39 million, a P/E ratio of 14.16 and a beta of 0.73. The business’s fifty day simple moving average is $6.93 and its 200-day simple moving average is $5.72.

Lifevantage (NASDAQ:LFVN) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.04). Lifevantage had a return on equity of 23.89% and a net margin of 2.94%.The company had revenue of $43.72 million during the quarter, compared to analysts’ expectations of $47.77 million. As a group, analysts forecast that Lifevantage Corporation will post 0.6 EPS for the current year.

Institutional Investors Weigh In On Lifevantage

A number of hedge funds have recently made changes to their positions in LFVN. Capital Management Corp VA boosted its stake in Lifevantage by 3.4% during the fourth quarter. Capital Management Corp VA now owns 2,134,574 shares of the company’s stock valued at $13,149,000 after buying an additional 70,398 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Lifevantage by 8.3% during the 4th quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock valued at $5,685,000 after buying an additional 70,900 shares in the last quarter. Wasatch Advisors LP grew its holdings in Lifevantage by 6.6% during the 2nd quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock valued at $5,838,000 after buying an additional 27,765 shares in the last quarter. Geode Capital Management LLC increased its stake in Lifevantage by 106.1% in the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after acquiring an additional 126,274 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in Lifevantage by 305.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 200,222 shares of the company’s stock worth $1,233,000 after acquiring an additional 150,785 shares during the last quarter. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.